✦ LIBER ✦

Current place of high-dose irinotecan chemotherapy in patients with metastatic colorectal cancer

✍ Scribed by Mohamed Hebbar; Marc Ychou; Michel Ducreux

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose, single-agent irinotecan as fi

✍ M. Ychou; J. Raoul; F. Desseigne; C. Borel; F. Caroli-Bosc; J. Jacob; J. Seitz; 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 279 KB

Retrospective analysis of cetuximab mono

✍ Ayako Mizota; Kohei Shitara; Chihiro Kondo; Motoo Nomura; Tomoya Yokota; Daisuke 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 202 KB

Incidence of delayed nausea and vomiting

✍ Paul J. Hesketh; Snezana M. Bosnjak; Vlada Nikolic; Bernardo Rapoport 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 158 KB

Survival of metastatic colorectal cancer

✍ Yiqun Chen; Zhenguo Qiu; Anmmd Kamruzzaman; Tom Snodgrass; Andrew Scarfe; Heathe 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 130 KB

First-line panitumumab plus irinotecan/5

✍ Claus-Henning Köhne; Ralf Hofheinz; Laurent Mineur; Henry Letocha; Richard Greil 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 584 KB

Chemotherapy for the Treatment of Patien

✍ William H. Isacoff; Katrina Borud 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 310 KB